Ex vivo drug screening informed targeted therapy for metastatic parotid squamous cell carcinoma

Nykänen, N., Mäkelä, R., Arjonen, A. et al. (8 more authors) (2021) Ex vivo drug screening informed targeted therapy for metastatic parotid squamous cell carcinoma. Frontiers in Oncology, 11. 735820.

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • Nykänen, N.
  • Mäkelä, R.
  • Arjonen, A.
  • Härmä, V.
  • Lewandowski, L.
  • Snowden, E.
  • Blaesius, R.
  • Jantunen, I.
  • Kuopio, T.
  • Kononen, J.
  • Rantala, J.K.
Copyright, Publisher and Additional Information:

© 2021 The Authors. This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Keywords: ex vivo drug screening; precision oncology; HER2; T-DM1; trastuzumab; molecular profiling; parotid squamous cell carcinoma
Dates:
  • Published: 16 September 2021
  • Published (online): 16 September 2021
  • Accepted: 23 August 2021
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 08 Oct 2021 08:06
Last Modified: 08 Oct 2021 08:06
Status: Published
Publisher: Frontiers Media SA
Refereed: Yes
Identification Number: 10.3389/fonc.2021.735820
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics